Investing

Bristol-Myers Squibb CEO Giovanni Caforio told CNBC on Friday the company is “one step closer to creating that great company” after shareholders greenlit a $74 billion takeover of Celgene. He expects that the deal for the cancer drugmaker will close in the third quarter. “When the two companies come together, we’ll have two growing businesses,”
0 Comments
Lloyd Blankfein is enjoying retirement. As his former fellow bank CEOs endured a multi-hour grilling in a Congressional hearing today, the ex-leader of Goldman Sachs tweeted sarcastically that he really missed his old job. Tweet Blankfein, who stepped down as Goldman CEO in October, tweeted a link to an article on the House Financial Services
0 Comments
As materials stocks build on their gains, one investing professional is getting even more constructive on the space. Witnessing the 4% pop this week in the Materials Select Sector SPDR Fund, a market-cap-weighted index that counts the stocks of Linde and DowDuPont among its top holdings, CFRA’s Todd Rosenbluth says investors should consider buying into
0 Comments
Activist investor Ancora Advisors announced on Monday a takeover bid for J. Alexander’s Holdings, a Nashville-based restaurant chain, according a letter filed with the Securities and Exchange Commission. Ancora, which already owns about 1.3 million J. Alexander’s shares, offered to buy J. Alexander’s for $11.75 per share in cash, or $186 million. The figure represents
0 Comments